NO20022811L - Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent - Google Patents

Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent

Info

Publication number
NO20022811L
NO20022811L NO20022811A NO20022811A NO20022811L NO 20022811 L NO20022811 L NO 20022811L NO 20022811 A NO20022811 A NO 20022811A NO 20022811 A NO20022811 A NO 20022811A NO 20022811 L NO20022811 L NO 20022811L
Authority
NO
Norway
Prior art keywords
oxazolidinones
benzoic acid
acid esters
hydroxyacetylpiperazine
substituent
Prior art date
Application number
NO20022811A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022811D0 (no
Inventor
Jr Jackson B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022811L publication Critical patent/NO20022811L/no
Publication of NO20022811D0 publication Critical patent/NO20022811D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022811A 1999-12-14 2002-06-13 Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent NO20022811D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14
PCT/US2000/032432 WO2001044212A1 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Publications (2)

Publication Number Publication Date
NO20022811L true NO20022811L (no) 2002-06-13
NO20022811D0 NO20022811D0 (no) 2002-06-13

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022811A NO20022811D0 (no) 1999-12-14 2002-06-13 Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent

Country Status (26)

Country Link
US (1) US6281210B1 (pt)
EP (1) EP1242395B1 (pt)
JP (1) JP2003516977A (pt)
KR (1) KR20020062332A (pt)
CN (1) CN1390211A (pt)
AR (1) AR026547A1 (pt)
AT (1) ATE288423T1 (pt)
AU (1) AU1805801A (pt)
BR (1) BR0015177A (pt)
CA (1) CA2387047A1 (pt)
CO (1) CO5261527A1 (pt)
CZ (1) CZ20022389A3 (pt)
DE (1) DE60017941T2 (pt)
EA (1) EA200200673A1 (pt)
ES (1) ES2236006T3 (pt)
HU (1) HUP0203787A3 (pt)
IL (1) IL150031A0 (pt)
MX (1) MXPA02005909A (pt)
NO (1) NO20022811D0 (pt)
PE (1) PE20010851A1 (pt)
PL (1) PL355369A1 (pt)
PT (1) PT1242395E (pt)
SK (1) SK5972002A3 (pt)
TW (1) TW544449B (pt)
WO (1) WO2001044212A1 (pt)
ZA (1) ZA200202953B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
WO2008073444A2 (en) * 2006-12-12 2008-06-19 The Johns Hopkins University Phou (perf), a persistence switch involved in persister formation as a drug target for persister bacteria
CA2692255A1 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014684A1 (en) * 1993-11-22 1995-06-01 The Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO1998054161A1 (en) * 1997-05-30 1998-12-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2001044212A1 (en) 2001-06-21
NO20022811D0 (no) 2002-06-13
SK5972002A3 (en) 2003-01-09
AU1805801A (en) 2001-06-25
ZA200202953B (en) 2003-09-23
HUP0203787A3 (en) 2005-06-28
CO5261527A1 (es) 2003-03-31
PE20010851A1 (es) 2001-08-17
EP1242395B1 (en) 2005-02-02
EA200200673A1 (ru) 2002-12-26
PL355369A1 (en) 2004-04-19
MXPA02005909A (es) 2002-10-23
DE60017941T2 (de) 2006-03-30
PT1242395E (pt) 2005-05-31
KR20020062332A (ko) 2002-07-25
EP1242395A1 (en) 2002-09-25
CZ20022389A3 (cs) 2002-10-16
CA2387047A1 (en) 2001-06-21
US6281210B1 (en) 2001-08-28
ES2236006T3 (es) 2005-07-16
ATE288423T1 (de) 2005-02-15
CN1390211A (zh) 2003-01-08
AR026547A1 (es) 2003-02-19
DE60017941D1 (de) 2005-03-10
JP2003516977A (ja) 2003-05-20
IL150031A0 (en) 2002-12-01
BR0015177A (pt) 2002-06-18
HUP0203787A2 (hu) 2003-07-28
TW544449B (en) 2003-08-01

Similar Documents

Publication Publication Date Title
NO20022811L (no) Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent
EA200200699A1 (ru) Оксазолидиноны, обладающие сульфоксиминовой функциональностью
DK1322648T3 (da) 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
TR200402157T2 (tr) Heteroaril süksinamidler ve metalloproteinaz inhibitörü olarak kullanımları
ATE227264T1 (de) Metalloproteinase-inhibitoren
DE60004803D1 (de) Pulmonare abgabe von protonierter/angesäuerter nukleinsäure
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
NO20002440D0 (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
AR024158A1 (es) Compuestos antibacterianos
DE602004004808D1 (de) Acyloxymethylcarbamat-prodrugs von oxazolidinonen
NO20035791L (no) Nye derivater av oksazolidinoner som antibakterielle midler
NZ515197A (en) Hydroxamic acid derivatives useful as matrix metalloprotease inhibitors
DE69615155D1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DE69805975T2 (de) 2-beta-substituierte-6-alkylidenpenizillansäure-derivate als beta-laktamase inhibitoren
DE69126758T2 (de) Benzamid-Derivate
EP2210597A3 (en) Bacterial virulence modifying agents
MXPA02002355A (es) Procedimiento para la produccion de derivados de acido naftiridin-3-carboxilico.
ATE140460T1 (de) Echinocandin-b-derivat
ES8504203A1 (es) Un procedimiento para preparar derivados de penem.
DE60004377D1 (de) Oral wirksame 7-alpha-alkyl androgene
TR199902387T2 (xx) Antibakteriyal ornat�lm�� 7-a�ilamino-3-(Metilhidrazono) Metil-Sefalosporinler ve ara �r�nleri.
NO20025101L (no) Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet
ATE335747T1 (de) Kristallines 3-cephem derivat
NO982879L (no) Vannlöselige antibiotika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application